钝性胸主动脉损伤TEVAR术后死亡风险因素分析
基于VQI数据库633例钝性胸主动脉损伤TEVAR病例,院内死亡率为7.3%,独立预测因素包括年龄≥60岁、肌酐≥1.2、男性、ISS>30及左锁骨下动脉受累,构建的简易评分模型预测院内死亡的C统计量为0.86。
要点
- 年龄≥60岁、肌酐≥1.2、男性、ISS>30及左锁骨下动脉受累是院内死亡的独立预测因素。
- 基于上述变量构建的简易评分模型预测院内死亡的C统计量为0.86,可用于风险分层。
核心结论
- TEVAR治疗钝性胸主动脉损伤的院内死亡率为7.3%,年龄≥60岁、肌酐≥1.2、男性、ISS>30及左锁骨下动脉受累与死亡独立相关。
- 基于上述变量构建的简易评分模型可稳健预测院内死亡,有助于患者选择和风险分层。
研究设计与样本
- 回顾性队列研究,查询Vascular Quality Initiative TEVAR数据集(2011年4月至2017年11月),纳入633例因钝性创伤行TEVAR的病例。
- 采用logistic回归识别院内死亡的独立预测因素,构建多变量预测模型,经10折交叉验证及早期/晚期拆分样本内外部验证,并简化为评分系统。
主要发现
- 患者中男性占73.9%,中位年龄39岁(四分位距27-56岁)。
- 18.6%记录为zone 2或近端受累,28.1%记录为左锁骨下动脉受累或治疗。
- 总体院内死亡率为7.3%。
关键数值与推荐
- 模型预测院内死亡的C统计量为0.86(95%CI 0.80-0.92)。
临床怎么用
- 对于钝性胸主动脉损伤拟行TEVAR的患者,可依据年龄、肌酐、性别、ISS及左锁骨下动脉受累情况评估院内死亡风险。
- 简易评分模型有助于识别高危患者,辅助治疗决策和风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite high use of endovascular repair, blunt thoracic aortic injury (BTAI) leads to significant mortality. We sought to identify risk factors and create a predictive model for mortality after thoracic endovascular aortic repair (TEVAR) based on available preoperative clinical data. METHODS: We queried the Vascular Quality Initiative TEVAR dataset from April 2011 to November 2017 to identify patients with BTAI as the indication for repair. Patient characteristics, injury grade, timing of repair, and technical aspects including left subclavian artery (LSCA) involvement and coverage were evaluated. Logistic regression was used to identify univariable predictors of the primary outcome of in-hospital mortality. A multivariable model was constructed to predict in-hospital mortality after TEVAR for traumatic aortic injury. The model was tested as a prediction tool, internally validated using 10-fold cross-validation approach, externally validated using early and late split samples, and finally simplified into a scoring system. RESULTS: We identified 633 TEVAR cases performed for blunt trauma. The majority of patients were male (73.9%) with median age of 39 years (interquartile range, 27-56 years). Although 18.6% documented zone 2 or proximal involvement, 28.1% documented involvement or treatment of the LSCA. 8.9% of repairs were performed for a grade 1 injury, with an increase from 6.4% in 2014 to 16.7% in 2017 (P = .04). The overall in-hospital mortality rate was 7.3%. Independent predictors of mortality were age 60 year or greater (odds ratio [OR], 11.33; 95% confidence interval [CI], 5.30-24.23; P < .001), creatinine 1.2 or greater (OR, 5.28; 95% CI, 2.46-11.34; P < .001), male gender (OR, 4.26; 95% CI, 1.53-11.84; P = .005), Injury Severity Score of greater than 30 (OR, 3.86; 95% CI, 1.74-8.57; P = .001), and LSCA involvement (OR, 2.25; 95% CI, 1.11-4.53; P = .02). The model predicted in-hospital mortality with a C-statistic of 0.86 (95% CI, 0.80-0.92), and a simplified model based on a point system had a similar C-statistic of 0.86 (95% CI, 0.80-0.92; P = .44). CONCLUSIONS: TEVAR for BTAI is associated with a 7.3% in-hospital mortality in the Vascular Quality Initiative. Treatment of grade 1 injuries has increased significantly in recent years. Factors most strongly associated with mortality include age, male gender, renal impairment, LSCA involvement, and high ISS score. A simple point score model based on these variables robustly predicts in-hospital mortality and may assist in appropriate patient selection and risk stratification.
引用
- Mohapatra A, Liang NL, Makaroun MS, et al. Risk factors for mortality after endovascular repair for blunt thoracic aortic injury. J Vasc Surg. 2019. PMID: 31526693. doi:10.1016/j.jvs.2019.07.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。